PWAM
FLGT icon

Park West Asset Management’s Fulgent Genetics FLGT Stock Holding History

Park West Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-447,942
Closed -$7.57M – 50
2025
Q1 		$7.57M Sell
447,942
-193,740
-30% -$3.3M 0.61% 42
2024
Q4 		$11.9M Sell
641,682
-71,902
-10% -$1.4M 0.95% 36
2024
Q3 		$15.5M Sell
713,584
-119,785
-14% -$2.68M 1.11% 30
2024
Q2 		$16.4M Buy
833,369
+103,586
+14% +$2.16M 1.2% 31
2024
Q1 		$15.8M Buy
729,783
+305,000
+72% +$7.57M 1.13% 26
2023
Q4 		$12.3M Buy
424,783
+79,649
+23% +$2.13M 1.2% 25
2023
Q3 		$9.23M Buy
+345,134
New +$11.8M 0.85% 28
2022
Q3 		– Sell
-629,882
Closed -$34.3M – 64
2022
Q2 		$34.3M Buy
629,882
+379,882
+152% +$20.9M 1.94% 14
2022
Q1 		$15.6M Buy
+250,000
New +$16.5M 0.54% 36

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Park West Asset Management's FLGT Position: Q2 2025 in Review

Park West Asset Management sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 447,942 shares — an estimated $7.57M sold.

Park West Asset Management first reported a position in FLGT in Q1 2022 and held it in 9 quarters. The position peaked at $34.3M in Q2 2022. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Park West Asset Management reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Park West Asset Management sold 447,942 Fulgent Genetics shares in Q2 2025, an estimated $7.57M.
  • Park West Asset Management first reported a position in Fulgent Genetics in Q1 2022 and held it in 9 quarters.
  • Park West Asset Management's Fulgent Genetics position peaked at $34.3M in Q2 2022.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Park West Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.